Stock screenerAll disclosures →
EDGAR →
HUMA
Conviction 2HealthcareScan · Mon, Jul 20, 2026HUMA$0.6507-2.11%
ResistanceSupportVol 14Insider buyInsider sellCongress buyCongress sell3
Vol MA14 9.01M
Apr 20May 6May 26Jun 11Jul 1Jul 20
Price0.6507
Change-2.11%
Gap+0.80%
Rel volume0.08×
Avg volume16.73M
Avg $ vol12.05M
SMA 200.7126
SMA 500.9646
SMA 2001.10
Price vs 50-32.54%
Price vs 200-41.00%
MA stackbearish
50/200 cross—
Supertrenddown · 0.8709
RSI (14)36
MACD hist0.00
MACD crossbull · 4d
Stoch %K / %D7 / 13
ADX (14)24
+DI / −DI15 / 25
RSI divergence—
MACD divergence—
ATR %+12.70%
ADR %11.82%
52w high2.73
52w low0.5745
From 52w high-76.16%
Above 52w low+13.26%
New 52w highNo
SqueezeOff
Bollinger width29.90%
%B0.21
Donchian pos12.74%
Donchian high0.9294
Donchian low0.6100
AVWAP (52w high)1.17
vs AVWAP high-44.19%
AVWAP (52w low)0.8673
vs AVWAP low-24.97%
OBV trendDown
Chaikin MF (20)-0.30
Today vs 20d0.08×
Avg vol (14d)9.01M
Avg vol (20d)16.73M
Avg $ vol (20d)12.05M
Market cap144.47M
RS 3m (vs SPY)-8.70%
RS 6m (vs SPY)-49.36%
RS line new highNo
Trend template0/8
Technical rank7.4
1 week-5.86%
1 month-32.84%
3 months-8.38%
6 months-40.85%
1 year-73.11%
YTD-33.26%
P/E-3.54
P/B12.43
P/S70.89
P/FCF-1.36
EPS-0.2600
Div yield—
ROE-351.28%
ROA-36.93%
Debt/Eq3.09
Current3.93
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth72.54%
Price target1.96
Target upside201.21%
Analyst ratingBuy
Institutional25.11%
Ent. value131.8M
Revenue495K
Net income-17.62M
Gross profit—
Free cash flow-105.93M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out222.02M
Employees184
ListedFri, Aug 27, 2021
Free float196.53M
Float %88.5%
Short interest31.6M
Days to cover1.3d
Short volume57.8%
Squeeze score50 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.09 vs −$0.10
Last surprise+10.0% beat
Setup gradeD
Conviction2 / 100
Pattern quality—
Tech rank7.4 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.51
Support0.6225
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in HUMA · 7 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Thomas H Tuberville senate · traded 2024-05-03 | Sell | $1K–$15K | 2024-05-03 | 2024-06-14 | |
Thomas H Tuberville senate · traded 2024-05-03 | Sell | $15K–$50K | 2024-05-03 | 2024-06-14 | |
Thomas H Tuberville senate · traded 2024-04-30 | Sell | $50K–$100K | 2024-04-30 | 2024-05-15 | |
Thomas H Tuberville senate · traded 2024-03-21 | Buy | $1K–$15K | 2024-03-21 | 2024-04-15 | |
Thomas H Tuberville senate · traded 2024-03-21 | Buy | $15K–$50K | 2024-03-21 | 2024-04-15 | |
Thomas H Tuberville senate · traded 2024-02-12 | Buy | $15K–$50K | 2024-02-12 | 2024-03-15 | |
Thomas H Tuberville senate · traded 2024-01-19 | Sell | $1K–$15K | 2024-01-19 | 2024-02-14 |
Insider activity
SEC Form 4 transactions in HUMA · 3 buys · 2 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Bamforth John Philip Director · Stock Options (right to buy) · 2026-06-11 | Grant | 80K | — | 2026-06-11 | 2026-06-12 |
Sebelius Kathleen Director · Common Stock · 2026-05-19 | Buy | 56.82K | $50K | 2026-05-19 | 2026-05-20 |
Parikh Shamik J Chief Medical Officer · Common Stock · 2026-05-18 | Sell | 45.89K | $41K | 2026-05-18 | 2026-05-20 |
Sander Dale A. CFO and Chief Corp. Dev. Off · Common Stock · 2026-05-18 | Sell | 45.89K | $41K | 2026-05-18 | 2026-05-20 |
Sander Dale A. CFO and Chief Corp. Dev. Off · Common Stock · 2026-05-18 | Other | — | — | 2026-05-18 | 2026-05-20 |
Constantino Michael T. Director · Common Stock · 2026-05-18 | Buy | 11K | $10K | 2026-05-18 | 2026-05-20 |
SEC filings
EDGAR filings in HUMA · 9 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.